GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » EV-to-EBITDA

Biovica International AB (OSTO:BIOVIC B) EV-to-EBITDA : -0.48 (As of May. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Biovica International AB's enterprise value is kr53.61 Mil. Biovica International AB's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was kr-110.85 Mil. Therefore, Biovica International AB's EV-to-EBITDA for today is -0.48.

The historical rank and industry rank for Biovica International AB's EV-to-EBITDA or its related term are showing as below:

OSTO:BIOVIC B' s EV-to-EBITDA Range Over the Past 10 Years
Min: -48.49   Med: -10.76   Max: -0.03
Current: -0.5

During the past 9 years, the highest EV-to-EBITDA of Biovica International AB was -0.03. The lowest was -48.49. And the median was -10.76.

OSTO:BIOVIC B's EV-to-EBITDA is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 9.67 vs OSTO:BIOVIC B: -0.50

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Biovica International AB's stock price is kr1.792. Biovica International AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was kr-2.574. Therefore, Biovica International AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Biovica International AB EV-to-EBITDA Historical Data

The historical data trend for Biovica International AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB EV-to-EBITDA Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -9.60 -12.79 -30.37 -15.49 -2.22

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.23 -2.22 -2.83 -0.67 -1.10

Competitive Comparison of Biovica International AB's EV-to-EBITDA

For the Biotechnology subindustry, Biovica International AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biovica International AB's EV-to-EBITDA falls into.



Biovica International AB EV-to-EBITDA Calculation

Biovica International AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=53.608/-110.847
=-0.48

Biovica International AB's current Enterprise Value is kr53.61 Mil.
Biovica International AB's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-110.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biovica International AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.792/-2.574
=At Loss

Biovica International AB's share price for today is kr1.792.
Biovica International AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.574.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Biovica International AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biovica International AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines